SUNNY

📅 Upcoming

🕒 Recent(90d)

News

• Steady stream of crossover rounds stock biotech's IPO pipeline
  Biotech crossover rounds could top $4.22 billion across about 28 rounds this year, PitchBook forecasts.
  biospace · 12d ago
• STAT+: Pharmalittle: We’re reading about a pancreatic cancer drug approval, a Trump deal with biotechs, and more
  The FDA approved a life-extending treatment for advanced pancreatic cancer from Revolution Medicines that is the first to attack a genetic cause
  stat · 24d ago
• STAT+: Pharmalittle: We’re reading about a setback for Eyepoint, a win for Amylyx, and more
  Eyepoint disclosed that a Phase 3 trial of its experimental treatment for a common cause of age-related blindness fell short of its primary goal
  stat · 1mo ago
• STAT+: Pharmalittle: We’re reading about an FDA rejection, 340B court battles, and more
  The FDA rejected a radiopharmaceutical therapy because of manufacturing issues, halting what would have been a competitor for Novartis
  stat · 1mo ago
• STAT+: He grew up near Boston, went to Harvard, and worked at MIT. Why did he found his startup in California?
  Boston, with its rising costs, high taxes, and business climate, is losing ground to rivals across the country, sometimes even in biotech.
  stat · 1mo ago
• STAT+: Pharmalittle: We’re reading about Moderna’s flu shot, a death in a gene-editing trial in China, and more
  In today's Pharmalittle newsletter: Moderna's mRNA flu shot approved, a death reported in a gene-editing trial in China, and more.
  stat · 1mo ago
• STAT+: Pharmalittle: We’re reading about FDA views on a Duchenne drug, GSK cost savings, and more
  The FDA said a Capricor stem cell treatment for Duchenne muscular dystrophy did not meet a Phase 3 trial's objectives — contrary to company claims
  stat · 1mo ago
• Sunny Pharmtech, Inc. Issues Voluntary Nationwide Recall of Cyclophosphamide for Injection, USP to the User Level Due to the Presence of Particulate Matter
  July 24, 2026 - Taoyuan City, Taiwan - Sunny Pharmtech, Inc is voluntarily recalling three lots of Cyclophosphamide for Injection, USP, 1g/vial and 2g/vial, to the User Level due to the presence of…
  fda_medwatch · 1mo ago
• STAT+: Pharmalittle: We’re reading about Lilly obesity drug data, a push for FDA to ban DTC ads, and more
  A study of Lilly's retatrutide weight loss drug in people with heart disease did not answer a crucial question — whether it reduces cardiovascular risk
  stat · 1mo ago
• STAT+: Pharmalittle: We’re reading about Novo suing Lilly over ‘deceptive’ ads, a fugitive’s secret life in biotech, and more
  Novo Nordisk sued Eli Lilly for allegedly running “deceptive” ads to make its obesity and diabetes drugs appear more effective
  stat · 2mo ago